logo

For the Inventor, By the Inventor

Michael Christopher Jewett

Evanston, IL, United States of America

Michael Christopher Jewett

LinkedIn

This inventor holds 30 USPTO granted patents and 19 published patent applications, primarily in Cell-Free Protein Synthesis. Top assignees: Northwestern University, Cornell University, University of Illinois. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Christopher Jewett. Retrieved from https://idiyas.com/inventor/michael-christopher-jewett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 90.0

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal30 out of 2,214 
 
Northwestern University
 patents
silverMedal8 out of 2,949 
 
Cornell University
 patents
bronzeMedal2 out of 2,424 
 
University of Illinois
 patents
4. 1 out of 53 
 
Lanzatech, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...
Areas of Expertise:
Cell-Free Protein Synthesis
Glycoprotein Production
Metabolic Engineering
Bioconjugate Vaccines
Ribosome Variants
N-Glycosylation
Non-Standard Amino Acids
Molecular Sensing
Protein Glycosylation
Prokaryotic Cell Lysates
Detoxified Prokaryotic Cell Lysates
30 patents (USPTO):Explore Patents
1. 12735734 - Low-cost, thermostable, lyophilized, cell-free protein synthesis platform (2026-09-15),
2. 12674799 - CELL-FREE EXPRESSION OF ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND ANTIBODY DERIVATIVES (2026-07-07),
3. 12624375 - METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELL LYSATES (2026-05-12),
4. 12503715 - Cell-free extract preparation protocol for enrichment of membrane vesicles and increased glycoprotein yields (2025-12-23),
5. 12421537 - Ribosome variants for sequence defined polymer synthesis (2025-09-23),
6. 12410456 - Cell-free glycoprotein synthesis (CFGPS) in prokaryotic cell lysates enriched with components for glycosylation (2025-09-09),
7. 12404533 - Bioconjugate vaccines' synthesis in prokaryotic cell lysates (2025-09-02),
8. 12365930 - Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates (2025-07-22),
9. 12325884 - Riboswitch-based fluoride sensing in cell-free extract (2025-06-10),
10. 12305211 - Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases (2025-05-20),
11. 12188072 - Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates (2025-01-07),
12. 12157908 - Cell-free protein synthesis platforms derived from clostridia extracts (2024-12-03),
13. 12098433 - On demand, portable, cell-free molecular sensing platform (2024-09-24),
14. 11913052 - Cell-free protein synthesis driven metabolic engineering (2024-02-27),
15. 11898187 - Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases (2024-02-13),

Title: **Innovative Contributions of Michael Christopher Jewett in Bioconjugate Vaccination**

Introduction

Michael Christopher Jewett, based in Evanston, IL, is an accomplished inventor with a remarkable portfolio of 20 patents. His innovative work primarily focuses on bioconjugate vaccines, with particular emphasis on novel methods and compositions that enhance vaccine effectiveness.

Latest Patents

Jewett's latest patents include groundbreaking advancements such as "Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers." This patent discloses methods and systems for cell-free synthesis of glycosylated carrier proteins, which can be utilized in vaccines, particularly in generating immune responses against bacterial polysaccharides. Another recent invention under his name is related to "Cell-free protein synthesis platforms derived from clostridia extracts," which involves compositions and kits for performing cell-free RNA transcription and protein synthesis using components from Clostridia species.

Career Highlights

Throughout his distinguished career, Jewett has held positions at prestigious institutions including Northwestern University and Cornell University. His research and innovations have significantly contributed to the fields of synthetic biology and immunology, making strides in vaccine technology.

Collaborations

Michael has collaborated with notable coworkers, including Jessica Carol Stark and Thapakorn Jaroentomeechai, whose collective expertise has further enhanced the impact of his research endeavors. These collaborations reflect Jewett's commitment to advancing scientific discovery through teamwork and shared insights.

Conclusion

In summary, Michael Christopher Jewett's contributions to the field of bioconjugate vaccines are notable, with his 20 patents showcasing the innovative methods he has developed. His work continues to pave the way for advancements in immunization strategies, ultimately aiming to improve public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…